<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2070">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05134220</url>
  </required_header>
  <id_info>
    <org_study_id>Electrolytes</org_study_id>
    <nct_id>NCT05134220</nct_id>
  </id_info>
  <brief_title>Electrolytes in Chronic Kidney Disease Patients With Acute Coronary Syndrome</brief_title>
  <official_title>Study of Serum Calcium and Phosphorus Level in Chronic Kidney Disease Patients With Acute Coronary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study of serum calcium and phosphorus level in chronic kidney disease patients and its&#xD;
      relation to occurrence of acute coronary syndrome in them.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective study to :&#xD;
&#xD;
        1. find the relation between electrolytes disturbance and renal diseases&#xD;
&#xD;
        2. the effect of electrolyte abnormalities on atherosclerosis&#xD;
&#xD;
        3. prevalence of acute coronary syndrome in patients with chronic kidney disease&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2021</start_date>
  <completion_date type="Anticipated">May 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Chronic kidney disease hospitalization</measure>
    <time_frame>from the day of admission to the day of discharge through study completion, an average of 28 weeks, in sohag university hospital</time_frame>
    <description>The CKD patient with and without acute coronary syndrome and estimated hazard ratios (HR) by use of multivariable Cox regression models.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Chronic Kidney Disease (CKD) patients with acute coronary syndrome</arm_group_label>
    <description>The CKD patients with or without dialysis who admitted to coronary care unit with chest pain consistent with ACS with any of following features :&#xD;
Electrocardiogram (ECG) changes:&#xD;
ST elevation.&#xD;
ST depression.&#xD;
T wave inversion.&#xD;
recent left bundle branch block.&#xD;
Troponin elevation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic Kidney Disease (CKD) patients without acute coronary syndrome</arm_group_label>
    <description>The CKD patient with or without dialysis with no previous history of ACS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Serum Calcium</intervention_name>
    <description>Serum calcium level.&#xD;
Serum phosphorus level. will be measured to all study population</description>
    <arm_group_label>Chronic Kidney Disease (CKD) patients with acute coronary syndrome</arm_group_label>
    <arm_group_label>Chronic Kidney Disease (CKD) patients without acute coronary syndrome</arm_group_label>
    <other_name>serum Phosphorus</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        two groups :&#xD;
&#xD;
          1. CKD patients with and without dialysis who admitted to Sohag university hospital with&#xD;
             acute coronary syndrome&#xD;
&#xD;
          2. CKD patients with and without dialysis who admitted to Sohag university hospital with&#xD;
             no previous or current history of acute coronary syndrome&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1-The CKD patients with or without dialysis who admitted to coronary care unit with&#xD;
             chest pain consistent with ACS with any of following features :&#xD;
&#xD;
             a- Electrocardiogram (ECG) changes:&#xD;
&#xD;
          -  ST elevation.&#xD;
&#xD;
          -  ST depression.&#xD;
&#xD;
          -  T wave inversion.&#xD;
&#xD;
          -  recent left bundle branch block.&#xD;
&#xD;
             b- Troponin T elevation.&#xD;
&#xD;
             2-The CKD patient with or without dialysis with no previous history of ACS.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who were diagnosed with primary hyperparathyroidism.&#xD;
&#xD;
          2. Acute Kidney injury (AKI) which is defined as any of the following:(KDIGO2012)&#xD;
&#xD;
               -  Increase in S.Cr by ≥ 0.3 mg/dl (≥ 26.5 μmol/l) within 48hours; or&#xD;
&#xD;
               -  Increase in S.Cr to ≥ 1.5 times baseline, which is known or presumed to have&#xD;
                  occurred within the prior 7 days;or&#xD;
&#xD;
               -  Urine volume &lt;0.5 ml/kg/h for 6 hours&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ahmed M YOUSEF, M.B.B.CH</last_name>
    <phone>01067439846</phone>
    <email>ahmed011032@med.sohag.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sohag university</name>
      <address>
        <city>Sohag</city>
        <zip>82524</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hassan A Elnoaman, Professor</last_name>
      <phone>0934570000</phone>
      <email>president@sohag.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998 Apr;31(4):607-17.</citation>
    <PMID>9531176</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 6, 2021</study_first_submitted>
  <study_first_submitted_qc>November 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2021</study_first_posted>
  <last_update_submitted>November 22, 2021</last_update_submitted>
  <last_update_submitted_qc>November 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Ahmed Mohamed Youssif</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

